Literature DB >> 6164117

Sleeve lobectomy: an alternative to pneumonectomy in the treatment of bronchial carcinoma.

I Ungar, I Gyeney, E Scherer, I Szarvas.   

Abstract

In a 20-year period between 1960 and 1979, 3,438 resections were done for primary cancer of the lung, the standard operation being either lobectomy or pneumonectomy in more than 90% of the cases. In 261 cases (7.4%) sleeve lobectomy was performed as an alternative to pneumonectomy in order to conserve pulmonary function as far as possible, provided the operation assured as equally radical a removal of the tumor as pneumonectomy. Long-term results could be evaluated for 113 cases operated before 1974. Fifty-seven (50%) were alive at least 5 years after operation, the follow-up being 100%. The postoperative mortality was 7.3% (19 cases). Indications for sleeve resection as well as some aspects of anesthesia and surgical technique are discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6164117     DOI: 10.1055/s-2007-1023439

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

1.  [Bronchoplastic and angioplastic operations in bronchial carcinoma].

Authors:  I Vogt-Moykopf; T Fritz; H Bülzebruck; N Merkle; G Daskos; G Meyer
Journal:  Langenbecks Arch Chir       Date:  1987

2.  Tracheobronchoplasty in Japan.

Authors:  Masazumi Maeda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-04

Review 3.  Sleeve resection of the bronchus and the pulmonary artery for pulmonary lesions.

Authors:  I Vogt-Moykopf; H Toomes; S Heinrich
Journal:  Jpn J Surg       Date:  1982

4.  Staging and management of lung cancer: sleeve resection.

Authors:  J Deslauriers; R J Mehran; C Guimont; J Brisson
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

5.  Bilateral sleeve lobectomy for metachronous multiple primary lung cancer.

Authors:  Y Watanabe; H Kobayashi; S Murakami; S Sawa; M Shinagawa; T Iwa
Journal:  Jpn J Surg       Date:  1986-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.